335 related articles for article (PubMed ID: 16198661)
1. Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia.
Grattagliano I; Russmann S; Palmieri VO; Portincasa P; Palasciano G; Lauterburg BH
Clin Pharmacol Ther; 2005 Oct; 78(4):422-32. PubMed ID: 16198661
[TBL] [Abstract][Full Text] [Related]
2. Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C.
Grattagliano I; Russmann S; Palmieri VO; Jüni P; Bihl F; Portincasa P; Palasciano G; Lauterburg BH
Hepatology; 2004 May; 39(5):1248-55. PubMed ID: 15122753
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage.
De Franceschi L; Fattovich G; Turrini F; Ayi K; Brugnara C; Manzato F; Noventa F; Stanzial AM; Solero P; Corrocher R
Hepatology; 2000 Apr; 31(4):997-1004. PubMed ID: 10733558
[TBL] [Abstract][Full Text] [Related]
4. Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin.
Lin CC; Yin MC
Clin Nutr; 2009 Feb; 28(1):34-8. PubMed ID: 19042060
[TBL] [Abstract][Full Text] [Related]
5. Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or death.
Costiniuk CT; Camacho F; Cooper CL
Clin Infect Dis; 2008 Jul; 47(2):198-202. PubMed ID: 18532889
[TBL] [Abstract][Full Text] [Related]
6. Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients.
Hino K; Murakami Y; Nagai A; Kitase A; Hara Y; Furutani T; Ren F; Yamaguchi Y; Yutoku K; Yamashita S; Okuda M; Okita M; Okita K
J Gastroenterol Hepatol; 2006 Aug; 21(8):1269-75. PubMed ID: 16872308
[TBL] [Abstract][Full Text] [Related]
7. S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia.
Altintas E; Sezgin O
Med Hypotheses; 2004; 63(5):834-7. PubMed ID: 15488656
[TBL] [Abstract][Full Text] [Related]
8. Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.
Bolchoz LJ; Morrow JD; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2002 Oct; 303(1):141-8. PubMed ID: 12235244
[TBL] [Abstract][Full Text] [Related]
9. Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability.
Seki R; Okamura T; Ide T; Kage M; Sata M; Uyesaka N; Maruyama T
J Physiol Sci; 2007 Feb; 57(1):43-9. PubMed ID: 17204208
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
Westhuyzen J; Saltissi D; Stanbury V
Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
[TBL] [Abstract][Full Text] [Related]
11. The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin.
Devine EB; Cross JT; Kowdley KV; Sullivan SD
Curr Med Res Opin; 2007 Jun; 23(6):1463-72. PubMed ID: 17559739
[TBL] [Abstract][Full Text] [Related]
12. IL-4 and reactive oxygen species are elevated in Egyptian patients affected with schistosomal liver disease.
Elsammak MY; Al-Sharkaweey RM; Ragab MS; Amin GA; Kandil MH
Parasite Immunol; 2008; 30(11-12):603-9. PubMed ID: 19067841
[TBL] [Abstract][Full Text] [Related]
13. Clinical and basal aspects of anemia during antiviral therapy for hepatitis C.
van Soest H; Renooij W; van Erpecum KJ
Ann Hepatol; 2009; 8(4):316-24. PubMed ID: 20009130
[TBL] [Abstract][Full Text] [Related]
14. Hydroxylamine treatment increases glutathione-protein and protein-protein binding in human erythrocytes.
Spooren AA; Evelo CT
Blood Cells Mol Dis; 1997 Dec; 23(3):323-36. PubMed ID: 9398534
[TBL] [Abstract][Full Text] [Related]
15. Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C.
Tanaka H; Miyano M; Ueda H; Fukui K; Ichinose M
Clin Exp Med; 2005 Dec; 5(4):190-5. PubMed ID: 16362799
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation does not prevent ribavirin-induced anemia.
González H; Ríos ME; Torres EA; Muñoz H; Arroyo J; Castro FJ
P R Health Sci J; 2003 Dec; 22(4):359-62. PubMed ID: 14768501
[TBL] [Abstract][Full Text] [Related]
17. Sulfhydryl groups of the erythrocyte membrane and their relation to glycolysis and drug-induced hemolytic anemia.
Zipursky A; Stephens M; Brown EJ; Larsen P
J Clin Invest; 1974 Mar; 53(3):805-12. PubMed ID: 4812440
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
Calanca LN; Fehr T; Jochum W; Fischer-Vetter J; Müllhaupt B; Wüthrich RP; Ambühl PM
J Clin Virol; 2007 May; 39(1):54-8. PubMed ID: 17409018
[TBL] [Abstract][Full Text] [Related]
19. Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes.
McMillan DC; Simson JV; Budinsky RA; Jollow DJ
J Pharmacol Exp Ther; 1995 Jul; 274(1):540-7. PubMed ID: 7616443
[TBL] [Abstract][Full Text] [Related]
20. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.
Coccia R; Spadaccio C; Foppoli C; Perluigi M; Covino E; Lusini M; Chello M
Clin Ther; 2007 Aug; 29(8):1706-17. PubMed ID: 17919551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
